Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Virology|March 11, 2017
Partial dysfunction of STAT1 profoundly reduces host resistance to flaviviral infectionMaximilian Larena, Mario LobigsJournal of Virology|April 23, 2002
Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virusEva Lee, Mario LobigsJournal of Virology|April 11, 2008
E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulenceEva Lee, Mario LobigsJournal of Virology|December 13, 2003
Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranesMario Lobigs, Eva LeeExpert Review of Vaccines|February 8, 2012
Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplexMario Lobigs, Michael S DiamondVaccine|March 18, 2003
Cross-protective and infection-enhancing immunity in mice vaccinated against flaviviruses belonging to the Japanese encephalitis virus serocomplexMario Lobigs, Megan Pavy, Roy HallImmunology and Cell Biology|April 6, 2004
Evidence that a mechanism for efficient flavivirus budding upregulates MHC class IMario Lobigs, Arno Müllbacher, Eva LeeImmunology and Cell Biology|May 20, 2003
MHC class I up-regulation by flaviviruses: Immune interaction with unknown advantage to host or pathogenMario Lobigs, Arno Müllbacher, Matthias RegnerEuropean Journal of Immunology|April 10, 2013
Cytolytic effector pathways and IFN-γ help protect against Japanese encephalitisMaximilian Larena, Matthias Regner, Mario LobigsPlos One|October 3, 2012
The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists, is critical for recovery in a mouse model of Japanese encephalitisMaximilian Larena, Matthias Regner, Mario LobigsPageof 5